Inactive Instrument

Company EnergySolutions Co Ltd Korea S.E.

Equities

Pharmaceuticals

End-of-day quote Korea S.E.
- - Intraday chart for EnergySolutions Co Ltd

Business Summary

HLB Life Science Co., Ltd. is a Korea-based company mainly engaged in the sale of pharmaceuticals. Along with subsidiaries, the Company operates its business through four segments. The Pharmaceutical Distribution segment is involved in the sale of pharmaceuticals and raw materials through SHINWHAADVANCE.CO.LTD. The Energy Business segment is engaged in energy service company (ESCO) business. It is equipped with equipments, assets and technical personnel to engage in energy saving investment business. The Bio Development segment is engaged in the development of extracorporeal circulation type bio space, hepatocyte treatment agents and hemostatic agents. The main products include anticancer drugs such as Tegatrabetan and Seclidemstat. The Other Business segment is involved in the investment of small business start-ups and venture businesses, as well as manufacturing and sale of light emitting diode (LED) products.

Sales per Business

KRW in Million2022Weight2023Weight Delta
Pharmaceutical Distribution
64.7 %
54,058 54.3 % 63,412 64.7 % +17.30%
Medicare
29.4 %
34,707 34.8 % 28,802 29.4 % -17.01%
Others
4.5 %
4,810 4.8 % 4,413 4.5 % -8.26%
Construction and Engineering
1.4 %
5,886 5.9 % 1,362 1.4 % -76.86%
Bio Development
0.0 %
130 0.1 % 1 0.0 % -99.12%

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
99.6 %
99,484 99.9 % 97,630 99.6 % -1.86%
Overseas
0.4 %
107 0.1 % 361 0.4 % +236.66%

Managers

Managers TitleAgeSince
Chief Executive Officer 66 -
Chief Executive Officer 58 15-12-10
Chief Tech/Sci/R&D Officer 54 -
Director/Board Member 51 -
Comptroller/Controller/Auditor 66 -

Members of the board

Members of the board TitleAgeSince
Chief Executive Officer 58 15-12-10
Chief Executive Officer 66 -
Director/Board Member 61 -
Director/Board Member 48 -
Director/Board Member 51 -
Director/Board Member 59 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 106,164,461 87,881,685 ( 82.78 %) 69,920 ( 0.0659 %) 82.78 %

Shareholders

NameEquities%Valuation
19,688,684 18.42 % 299 M
Korea Investment Management Co., Ltd.
0.0145 %
15,512 0.0145 % 235 633
DFA Australia Ltd.
0.006725 %
7,189 0.006725 % 109 203
KB Asset Management Co., Ltd.
0.006552 %
7,004 0.006552 % 106 393
Mirae Asset Global Investments Co., Ltd.
0.005630 %
6,018 0.005630 % 91 415

Holdings

NameEquities%Valuation
2,681,798 2.05% 209,563,714 $
4,322,044 13.65% 118,143,894 $
3,365,165 20.55% 10,861,003 $
2,074,688 2.93% 9,616,386 $
223,638 0.30% 2,245,932 $

Company contact information

HLB Life Science Co., Ltd.

3-502, Pangyo Seven Venture Valley 1 15 Pangyo-ro 228beon-gil

13487, Seongnam-si

+

http://www.hlb-ls.com
address EnergySolutions Co Ltd
  1. Stock Market
  2. Equities
  3. A067630 Stock
  4. Stock
  5. Company EnergySolutions Co Ltd